RxDoctor Payments Data

Laura Moe

Family · Fort Worth, TXNPI 1174088652

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $134,069 of the $158,015 with a category attached, or 84.8%. AbbVie accounts for 100.0% of it on its own, with 2 other manufacturers making up the rest. Among family clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$158,015in general payments, 2019–2025

Across 337 payments — averaging $468.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$158K
  • Johnson & Johnson$29
  • Galderma Laboratories, L.p.$18

What the payments were for

  • Speaking & faculty fees$134,06985%
  • Travel & lodging$15,84910%
  • Food & beverage$8,0555%
  • Education$420%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)335$157,969
Johnson & Johnson1$29
Galderma Laboratories, L.p.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$158,015 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas →

Other family in Fort Worth

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →